Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAvid Bioservices, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q2 2024 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q3 2024 | 1 | -$0.06 | -$0.05 | -$0.06 |
| Q4 2024 | 2 | -$0.12 | -$0.11 | -$0.12 |
| Q1 2025 | 1 | -$0.06 | -$0.05 | -$0.06 |
| Q2 2025 | 1 | -$0.03 | -$0.03 | -$0.03 |
| Q3 2025 | 1 | -$0.04 | -$0.03 | -$0.04 |
| Q4 2025 | 1 | -$0.09 | -$0.08 | -$0.09 |
| Q1 2026 | 1 | -$0.03 | -$0.03 | -$0.03 |
| Q2 2026 | 1 | $0.01 | $0.02 | $0.02 |
| Q3 2026 | 1 | $0.03 | $0.03 | $0.03 |
| Q4 2026 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q1 2027 | 1 | $0.03 | $0.03 | $0.03 |
| Q2 2027 | 1 | $0.09 | $0.09 | $0.09 |
Avid Bioservices, Inc. Earnings Date And Information
Avid Bioservices, Inc. last posted its earnings results on Tuesday, December 10th, 2024. The company reported $-0.22 earnings per share for the quarter, missing analysts' consensus estimates of $-0.12 by $0.1. The company had revenue of 33.48 M for the quarter and had revenue of 139.91 M for the year. Avid Bioservices, Inc. has generated $-2 earnings per share over the last year ($-2.23 diluted earnings per share) and currently has a price-to-earnings ratio of -5.16. Avid Bioservices, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based on prior year's report dates.
Avid Bioservices, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 12/10/2024 | Q2 2025 | -$0.12 | -$0.27 | -0.15 | $33.80 M | $33.48 M |
| 09/09/2024 | Q1 2025 | -$0.02 | -$0.09 | -0.07 | $40.76 M | $40.17 M |
| 04/28/2024 | Q4 2024 | -$1.94 | $42.98 M | |||
| 01/29/2024 | Q3 2024 | -$0.09 | $33.10 M | $33.82 M | ||
| 12/07/2023 | Q2 2024 | -$0.09 | -$0.15 | -0.06 | $33.22 M | $25.40 M |
| 09/07/2023 | Q1 2024 | -$0.03 | -$0.03 | -0.01 | $36.08 M | $37.73 M |
| 06/21/2023 | Q4 2023 | -$0.02 | -$0.00 | 0.02 | $39.80 M | |
| 03/13/2023 | Q3 2023 | $0.03 | $0.01 | -0.02 | $36.32 M | $38.02 M |
| 12/06/2022 | Q2 2023 | -$0.00 | -$0.02 | -0.02 | $32.05 M | $34.76 M |
| 09/06/2022 | Q1 2023 | $0.07 | $0.03 | -0.04 | $33.44 M | $36.69 M |
| 06/29/2022 | Q4 2022 | $0.01 | $1.87 | 1.86 | $31.23 M | |
| 03/08/2022 | Q3 2022 | $0.05 | $0.04 | -0.01 | $26.59 M | $31.51 M |
| 12/07/2021 | Q2 2022 | $0.04 | $0.06 | 0.02 | $24.02 M | $26.11 M |
| 09/08/2021 | Q1 2022 | $0.04 | $0.10 | 0.06 | $27.81 M | $30.75 M |
| 06/29/2021 | Q4 2021 | -$0.00 | -$0.04 | -0.04 | $27.61 M | |
| 03/08/2021 | Q3 2021 | $0.00 | $0.01 | 0.01 | $19.07 M | $21.81 M |
| 12/02/2020 | Q2 2021 | -$0.06 | $0.01 | 0.07 | $15.49 M | $21.06 M |
| 09/01/2020 | Q1 2021 | -$0.07 | $0.06 | 0.13 | $16.50 M | $25.39 M |
| 06/30/2020 | Q4 2020 | -$0.16 | -$0.08 | 0.08 | $12.55 M | |
| 03/10/2020 | Q3 2020 | -$0.04 | -$0.04 | 0 | $15.42 M | $13.59 M |
Avid Bioservices, Inc. Earnings: FAQ's
When is Avid Bioservices, Inc.'s earnings date?
Avid Bioservices, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based off last year's report dates.
How can I listen to Avid Bioservices, Inc.'s earnings conference
call?
The conference call for Avid Bioservices, Inc.'s latest earnings report can be listened to online.
How can I read Avid Bioservices, Inc.'s conference call transcript?
The conference call transcript for Avid Bioservices, Inc.'s latest earnings report can be read online.
How much revenue does Avid Bioservices, Inc. generate each year?
Avid Bioservices, Inc. (:CDMO) has a recorded annual revenue of $139.91 M.
How much profit does Avid Bioservices, Inc. generate each year?
Avid Bioservices, Inc. (:CDMO) has a recorded net income of $139.91 M. Avid Bioservices, Inc. has generated $-2.23 earnings per share over the last four quarters.
What is Avid Bioservices, Inc.'s price-to-earnings ratio?
Avid Bioservices, Inc. (:CDMO) has a price-to-earnings ratio of -5.16 and price/earnings-to-growth ratio is 0.98.